3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Bronchogenic
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
3
Observation
2
Magnetic Resonance Imaging
2
Biopsy
2
tislelizumab
1
pembrolizumab
1
fluorocholine
1
atezolizumab
1
abiraterone
1
Videotape Recording
1
TIC10 compound
1
Surveys and Questionnaires
1
Specimen Handling
1
Referral and Consultation
1
Prostatectomy
1
Preoperative Exercise
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Nephroureterectomy
1
Mass Screening
1
Mammography
1
Interleukin-15
1
High-Intensity Interval Training
1
Hematologic Tests
1
Food
1
Endosonography
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease
×
Interleukin-15
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled